Skip to main content
. 2013 Nov-Dec;7(11-12):E692–E698. doi: 10.5489/cuaj.235

Table 1.

Baseline characteristics of study participants

Variable All participants (n=26) AET (n=13) RET (n=13) p value
Age (years) 72.1 (8.4) 70.6 (8.1) 73.6 (8.8) 0.376
Categorical variables
Caucasian 17 (65.4) 11 (84.6) 8 (61.5) 0.242
Married 19 (73.1) 9 (69.2) 10 (76.9) 0.549
Post-high school education 18 (69.2) 11 (84.6) 7 (53.8) 0.328
Retired 18 (69.2) 8 (61.5) 10 (76.9) 0.700
Gleason score
  6–7 11 (42.3) 6 (46.2) 5 (38.5)
  8–10 12 (46.2) 6 (46.2) 6 (46.2) 0.288
  Not available 3 (11.5) 1 (7.7) 2 (15.4)
T-Stage
  T1 & T2 16 (61.5) 8 (61.5) 8 (61.5)
  T3 & T4 8 (30.8) 5 (38.5) 3 (23.1) 0.050
  Not available 2 (7.7) 0 (0.0) 2 (15.4)
Treatment
  LHRH-a alone 12 (46.2) 5 (38.5) 7 (53.8)
  LHRH-a + anti-androgen 12 (46.2) 7 (53.8) 5 (38.5) 0.542
  Anti-androgen alone 2 (7.7) 1 (7.7) 1 (7.7)

Data for continuous variables are presented as Mean (SD); p-value for between-group differences using independent sample t-test. Data for categorical variables are presented as Frequency (% of group); p value for χ2; LHRH-a: luteinizing hormone-releasing hormone agonist; ADT: androgen deprivation therapy; AET: aerobic exercise training; RET: resistance exercise training.